Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Item
http://www.wikidata.org/entity/Q24193435
Deprescribing versus continuation of chronic proton pump inhibitor use in adultsValidity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review.Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.Dosing down with biologic therapies: a systematic review and clinicians' perspective.Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature reviewOptimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Biological tapering and sonographic flare in rheumatoid arthritis.Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis.Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.Anti-TNF Withdrawal in Inflammatory Bowel Disease.Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis
P2860

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Item
http://www.wikidata.org/entity/Q24193435
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
type
label
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
prefLabel
Down-titration and discontinua ...... ents with low disease activity
@ast
Down-titration and discontinua ...... ents with low disease activity
@en
Down-titration and discontinua ...... ents with low disease activity
@en-gb
Down-titration and discontinua ...... ents with low disease activity
@nl
P1433
P1476
P2093
P2860
P31
P3181
P356
P50
P577
P698
P3181
P356
P1433
P1476
Down-titration and discontinua ...... ents with low disease activity
@en
P2093
P2860
P31
P3181
P356
10.1002/14651858.CD010455.PUB2
P50
P577
P698